Skip to main content
Top
Literature
1.
go back to reference Schreiner MS (2003) Paediatric clinical trials: redressing the imbalance. Nat Rev Drug Discov 2:949–961PubMedCrossRef Schreiner MS (2003) Paediatric clinical trials: redressing the imbalance. Nat Rev Drug Discov 2:949–961PubMedCrossRef
2.
go back to reference Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–558PubMedCrossRef Pandolfini C, Bonati M (2005) A literature review on off-label drug use in children. Eur J Pediatr 164:552–558PubMedCrossRef
3.
go back to reference Cuzzolin L, Atzei A, Fanos V (2006) Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5:703–718PubMedCrossRef Cuzzolin L, Atzei A, Fanos V (2006) Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5:703–718PubMedCrossRef
4.
go back to reference Stanton A, Jensen C, Nussberger J, Obrien E (2003) Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension 42:1137–1143PubMedCrossRef Stanton A, Jensen C, Nussberger J, Obrien E (2003) Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension 42:1137–1143PubMedCrossRef
5.
go back to reference Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I (2010) Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats. Am J Physiol Renal Physiol 299:F758–F766PubMedCrossRef Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I (2010) Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats. Am J Physiol Renal Physiol 299:F758–F766PubMedCrossRef
7.
go back to reference Spiller HA (2008) Hypotension after ingestion of aliskiren. Clin Toxicol 46:916–917CrossRef Spiller HA (2008) Hypotension after ingestion of aliskiren. Clin Toxicol 46:916–917CrossRef
Metadata
Title
Not ready for prime time: aliskiren for treatment of hypertension or proteinuria in children
Author
Joseph T. Flynn
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 3/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1726-4

Other articles of this Issue 3/2011

Pediatric Nephrology 3/2011 Go to the issue